Pak Fah Yeow International Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pak Fah Yeow International.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 12.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why We Think Pak Fah Yeow International (HKG:239) Might Deserve Your Attention Today
Nov 21Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Aug 31Calculating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Jun 01Does Pak Fah Yeow International (HKG:239) Have A Healthy Balance Sheet?
Dec 12Pak Fah Yeow International's (HKG:239) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02The Strong Earnings Posted By Pak Fah Yeow International (HKG:239) Are A Good Indication Of The Strength Of The Business
Sep 24Pak Fah Yeow International (HKG:239) Will Pay A Larger Dividend Than Last Year At HK$0.028
Aug 28Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
May 11Consider This Before Buying Pak Fah Yeow International Limited (HKG:239) For The 2.9% Dividend
Feb 21What Type Of Returns Would Pak Fah Yeow International's(HKG:239) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 17How Does Pak Fah Yeow International Limited (HKG:239) Fare As A Dividend Stock?
Nov 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pak Fah Yeow International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 260 | 105 | 145 | 148 | N/A |
9/30/2023 | 238 | 97 | 118 | 120 | N/A |
6/30/2023 | 217 | 88 | 92 | 92 | N/A |
3/31/2023 | 183 | 59 | 66 | 66 | N/A |
12/31/2022 | 148 | 30 | 40 | 40 | N/A |
9/30/2022 | 144 | 28 | 41 | 41 | N/A |
6/30/2022 | 141 | 26 | 41 | 42 | N/A |
3/31/2022 | 141 | 32 | 55 | 56 | N/A |
12/31/2021 | 141 | 38 | 70 | 70 | N/A |
9/30/2021 | 131 | 29 | 63 | 64 | N/A |
6/30/2021 | 121 | 19 | 56 | 57 | N/A |
3/31/2021 | 115 | -10 | 32 | 32 | N/A |
12/31/2020 | 110 | -38 | 8 | 8 | N/A |
9/30/2020 | 114 | -35 | 6 | 7 | N/A |
6/30/2020 | 119 | -32 | 4 | 5 | N/A |
3/31/2020 | 134 | 2 | 26 | 27 | N/A |
12/31/2019 | 148 | 36 | 48 | 49 | N/A |
9/30/2019 | 160 | 40 | 63 | 64 | N/A |
6/30/2019 | 171 | 45 | 78 | 78 | N/A |
3/31/2019 | 156 | 41 | 66 | 67 | N/A |
12/31/2018 | 142 | 37 | 54 | 56 | N/A |
9/30/2018 | 144 | 52 | 58 | 60 | N/A |
6/30/2018 | 147 | 66 | 62 | 64 | N/A |
3/31/2018 | 163 | 84 | 80 | 81 | N/A |
12/31/2017 | 180 | 103 | 97 | 99 | N/A |
9/30/2017 | 183 | 104 | N/A | 85 | N/A |
6/30/2017 | 186 | 106 | N/A | 72 | N/A |
3/31/2017 | 185 | 84 | N/A | 69 | N/A |
12/31/2016 | 183 | 61 | N/A | 65 | N/A |
9/30/2016 | 176 | 48 | N/A | 67 | N/A |
6/30/2016 | 170 | 34 | N/A | 69 | N/A |
3/31/2016 | 176 | 48 | N/A | 71 | N/A |
12/31/2015 | 183 | 61 | N/A | 72 | N/A |
9/30/2015 | 189 | 91 | N/A | 72 | N/A |
6/30/2015 | 195 | 122 | N/A | 71 | N/A |
3/31/2015 | 191 | 134 | N/A | 56 | N/A |
12/31/2014 | 187 | 146 | N/A | 41 | N/A |
9/30/2014 | 176 | 121 | N/A | 52 | N/A |
6/30/2014 | 164 | 96 | N/A | 63 | N/A |
3/31/2014 | 163 | 83 | N/A | 60 | N/A |
12/31/2013 | 162 | 71 | N/A | 56 | N/A |
9/30/2013 | 149 | 68 | N/A | 45 | N/A |
6/30/2013 | 136 | 66 | N/A | 34 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 239's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if 239's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 239's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 239's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 239's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 239's Return on Equity is forecast to be high in 3 years time